NSC |
Compound |
Enrichment |
Correlation |
NSC 727729 |
1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one |
0.0238174255956147 |
0.19555033 |
NSC 730708 |
Null |
0.0238174255956147 |
0.44901891 |
NSC 732825 |
N1-(4-methoxyphenyl)-4-(1-benzyl-4-chloro-2,5-dioxo-2,5-dihy dro-1H-3-pyrrolylamino)benzamide |
0.0238174255956147 |
0.34084951 |
NSC 732954 |
Null |
0.0238174255956147 |
0.32303085 |
NSC 736818 |
Null |
0.0238174255956147 |
0.54063227 |
NSC 742554 |
7H-Furo[3,2-g][1]benzopyran-7-one, 4-[[(2E)-5-[4'-[[(2E)-6,7-dihydroxy-3,7-dimethyl-2-octenyl]oxy]-5,5-dimethyl-spiro[1,3-dioxolane-2,7'-[7H]furo[3,2-g][1]benzopyran]-4-yl]-3-methyl-2-pentenyl]oxy]-, |
0.0238174255956147 |
0.10956871 |
NSC 89671 |
Ascotoxin |
0.0238174255956147 |
0.027171246 |
NSC 132277 |
Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) |
0.024108502230778 |
0.13004876 |
NSC 13275 |
Null |
0.024108502230778 |
0.4242856 |
NSC 133118 |
2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) |
0.024108502230778 |
0.18480129 |